drugset / Trial / NCT06062680

Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects

NCT06062680 ↗

Phase 1 Unknown 15 enrolled Jiangsu HengRui Medicine Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

This study used a single-center, randomized, open-label, three-period, crossover trial design. Fifteen healthy subjects were planned to be enrolled, and the subjects were randomly assigned to any group A, B and C in the order of screening, with 5 cases in each group

Timeline

Start
2023-10
Primary completion
2023-11-15
Completion
2023-11-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Herombopag Olamine Unknown 7.5 mg —